Abstract
Ceftaroline fosamil and ceftobiprole medocaril are recently approved fifth-generation cephalosporins that are active against serious Gram-negative and Gram-positive bacterial infections, including methicillin-resistant Staphylococcus aureus (MRSA). This article provides a brief background on the mechanisms of β-lactam antibacterial resistance and reviews the patent literature on synthetic routes and final forms of ceftaroline fosamil and ceftobiprole medocaril.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
